Exploring Time Limited Vs Continuous Therapy In Cll Treatment
Exploring Time Limited Vs Continuous Therapy In Cll Treatment reveals several interesting facts.
- Adam Kittai, MD, Ohio State University, Columbus, OH, comments on the prognostic value of different adverse prognostic features ...
- During the ESH Translational Research Conference, the Lymphoma Hub was pleased to speak with Anthony Mato, Memorial ...
- Jennifer Woyach, MD, Ohio State University College of Medicine, Columbus, OH, discusses how patient preference may influence ...
- Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, discusses factors influencing the choice between ...
- Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...
In-Depth Information on Time Limited Vs Continuous Therapy In Cll Treatment
In this video, Anthony Mato, MD, MSCE, Memorial Sloan Kettering Cancer Center, New York, NY, shares some insights into the ... Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, discusses Inhye Ahn, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the limitations of Barbara Eichhorst, MD, University of Cologne, Cologne, Germany, discusses patient selection for
Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, Netherlands, compares defined duration
Stay tuned for more updates related to Time Limited Vs Continuous Therapy In Cll Treatment.